Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-059650
Date:2019-12-07
Issuer: COMMUNITY HEALTH SYSTEMS INC (CYH)
Original Submission Date:

Reporting Person:

AARON THOMAS J
4000 MERIDIAN BOULEVARD
FRANKLIN, TN 37067

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-12-07 F 26,372 d $3.62 241,515 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 4.99 deemed execution date 0 ( ) 2020-03-01 2029-02-28 common stock 37,500 $4.99 37,500 direct
PERFORMANCE BASED RESTRICTED 0.0 deemed execution date 0 ( ) common stock 12,500 $0.00 12,500 direct
PERFORMANCE BASED RESTRICTED 0.0 deemed execution date 0 ( ) common stock 50,000 $0.00 50,000 direct
PERFORMANCE BASED RESTRICTED 0.0 deemed execution date 0 ( ) common stock 75,000 $0.00 75,000 direct
Footnotes
IDfootnote
f1 the vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2017 and 12/31/2019 (the "2017-2019 performance period"). the target number (100%) of the total performance-based restricted shares is reported in the table set forth above. between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2017-2019 performance period.
f2 the vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 performance period"). the target number (100%) of the total performance-based restricted shares is reported in the table set forth above. between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 performance period.
f3 the vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 performance period"). the target number (100%) of the total performance-based restricted shares is reported in the table set forth above. between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 performance period.

Elevate your investments